Early Life
Johannes von Baumbach was born in 2006, making him 19 years old as of 2025. He is part of the von Baumbach family, known for their long-standing ownership of Boehringer Ingelheim.
Rise to Success
Johannes's wealth stems from his inheritance of a stake in Boehringer Ingelheim. The company was founded in 1885 and has grown into a global leader in the pharmaceutical industry.
Key Business Strategies
Boehringer Ingelheim focuses on developing and producing medicines and treatments for both human and animal health. The company is known for therapies for respiratory diseases (COPD and asthma), treatments for type 2 diabetes, and anticoagulation drugs. The company has a workforce of roughly 54,500 people across 78 countries and generated about $6.7 billion in revenue by 2024.
Philanthropy
Information on Johannes von Baumbach's specific philanthropic activities is limited due to the family's preference for privacy. However, the family's involvement in the company suggests a commitment to supporting medical advancements and patient care.